Association of SPI1 Haplotypes with Altered SPI1 Gene Expression and Alzheimer’s Disease Risk
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index; 27 of the 37 sources its claims cite were checked for support.
Abstract
BACKGROUND: Genetic studies reveal that single-nucleotide polymorphisms (SNPs) of SPI1 are associated with Alzheimer's disease (AD), while their effects in the Chinese population remain unclear. OBJECTIVE: We aimed to examine the AD-association of SPI1 SNPs in the Chinese population and investigate the underlying mechanisms of these SNPs in modulating AD risk. METHODS: We conducted a genetic analysis of three SPI1 SNPs (i.e., rs1057233, rs3740688, and rs78245530) in a Chinese cohort (n = 333 patients with AD, n = 721 normal controls). We also probed public European-descent AD cohorts and gene expression datasets to investigate the putative functions of those SNPs. RESULTS: We showed that SPI1 SNP rs3740688 is significantly associated with AD in the Chinese population (odds ratio [OR] = 0.72 [0.58-0.89]) and identified AD-protective SPI1 haplotypes β (tagged by rs1057233 and rs3740688) and γ (tagged by rs3740688 and rs78245530). Specifically, haplotypes β and γ are associated with decreased SPI1 gene expression level in the blood and brain tissues, respectively. The regulatory roles of these haplotypes are potentially mediated by changes in miRNA binding and the epigenetic landscape. Our results suggest that the AD-protective SPI1 haplotypes regulate pathways involved in immune and neuronal functions. CONCLUSION: This study is the first to report a significant association of SPI1 with AD in the Chinese population. It also identifies SPI1 haplotypes that are associated with SPI1 gene expression and decreased AD risk.
Overview
CoChat Summary
TL;DR
This study reports that SPI1 SNP rs3740688 and haplotypes β and γ are associated with reduced Alzheimer’s disease (AD) risk in a Hong Kong Chinese cohort, with haplotype γ also showing protective effects in APOE ε3 homozygous European-descent cohorts. The protective haplotypes are linked to decreased SPI1 expression in blood or brain and to immune/neuronal pathways.
Key findings
- In the Chinese cohort (333 AD, 721 controls), rs3740688 was significantly AD-protective (OR = 0.72 [0.58–0.89]; adjusted Beta = –0.326±0.109, p = 0.003; APOE-adjusted Beta = –0.350±0.113, p = 0.002).
- Haplotypes β (rs1057233–rs3740688) and γ (rs3740688–rs78245530) were AD-protective in Chinese participants (β: Beta = –0.337±0.118, p = 0.004; γ: Beta = –0.726±0.342, p = 0.034), with β remaining significant after APOE adjustment (Beta = –0.368±0.122, p = 0.003).
- In European-descent APOE33 participants, haplotype γ was AD-protective (Beta = –0.213±0.137, p = 0.030), and meta-analysis across Chinese and European APOE33 participants gave Beta = –0.248±0.133, p = 0.015, though this did not pass the multiple-testing threshold (0.05/6 = 0.0083).
- Haplotype γ was associated with delayed AD onset (HR = 0.54 [0.30–0.95], p = 0.035) and better MMSE performance (Beta = 0.173±0.066, p = 0.009) in APOE33 European-descent cohorts; it was also associated with decreased SPI1 expression in cortex (Beta = –0.447±0.166, p = 0.008) and frontal cortex (Beta = –0.361±0.174, p = 0.039), while haplotype β was associated with decreased SPI1 expression in blood (Beta = –0.119±0.060, p = 0.047) and strongly in monocytes/macrophages (p < 2×10–9).
Methods
- Genetic association analysis of three SPI1 SNPs (rs1057233, rs3740688, rs78245530) in a Hong Kong Chinese AD cohort (n = 333 AD, n = 721 normal controls), using TaqMan genotyping and whole-genome sequencing data.
- Replication and endophenotype analyses used European-descent AD cohorts (ADNI, ADC, LOAD; n = 5,094 AD, n = 4,663 controls) and expression datasets (GTEx, BRAINEAC, Cardiogenics), with haplotype-based logistic regression adjusted for age, sex, APOE, and principal components where applicable.
- Meta-analysis used METASOFT with random-effects and RE2 models; downstream analyses included Gene Ontology, protein–protein interaction networks, miRNA-binding prediction, and epigenetic annotation of SPI1 regulatory regions.
Limitations
- The paper states that larger cohorts and additional independent cohorts are needed to confirm the SPI1 haplotype–AD associations and their effects on age of onset and cognition, and that functional studies are needed to elucidate how haplotypes modulate SPI1 expression and microglial AD-associated functions.
- Evident from the text: the European-descent haplotype γ AD-protective effect was observed only in APOE33 participants, and the cross-population meta-analysis did not pass the multiple-testing correction threshold.
- Evident from the text: some key findings rely on public datasets and in silico/epigenetic annotations, and the homozygous haplotype γ carrier analysis in LOAD involved only n = 10 individuals.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
16 Valid · 3 Not valid · 9 Not checked · 71 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“genome-wide association studies (GWASs) suggest that SPI1—which encodes PU.1, a transcription factor that regulates the expression of immune-related genes in myeloid cells [7], is associated with AD [4–6].”
§ Association of SPI1 Haplotypes with Altered SPI1 Gene Expression and Alzheimer’s Disease Risk > INTRODUCTION
What the sources say
- Supportedcites [4] Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, et al. (2019) Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat Genet 51, 414– 430. 30820047 PMC6463297 source
In Results, under “Candidate gene prioritization at genome-wide loci” (page not provided), the paper identifies an SPI1 locus and reports evidence that a variant affects both SPI1 expression and Alzheimer’s disease risk. This supports the hedged claim that GWAS findings suggest an association. (LLM, conf=0.90)
- Supportedcites [5] Huang KL, Marcora E, Pimenova AA, Di Narzo AF, Kapoor M, Jin SC, Harari O, Bertelsen S, Fairfax BP, Czajkowski J, Chouraki V, Grenier-Boley B, Bellenguez C, Deming Y, McKenzie A, Raj T, Renton AE, Budde J, Smith A, Fitzpatrick A, Bis JC, DeStefano A, Adams HHH, Ikram MA, Van Der Lee S, Del-Aguila JL, Fernandez MV, Ibañez L, Sims R, Escott-Price V, Mayeux R, Haines JL, Farrer LA, Pericak-Vance MA, Lambert JC, Van Duijn C, Launer L, Seshadri S, Williams J, Amouyel P, Schellenberg GD, Zhang B, Borecki I, Kauwe JSK, Cruchaga C, Hao K, Goate AM (2017) A common haplotype lowers PU.1 expression in my source
The Results section (‘Conditional and SMR analysis of the SPI1/CELF1 locus’) identifies SPI1 as the most likely gene underlying the association with Alzheimer’s disease at this locus. The Discussion likewise nominates SPI1 as the gene responsible for the disease association. Page numbers are not supplied in our copy. (LLM, conf=0.93)
- Could not verifycites [6] Marioni RE, Harris SE, Zhang Q, McRae AF, Hagenaars SP, Hill WD, Davies G, Ritchie CW, Gale CR, Starr JM, Goate AM, Porteous DJ, Yang J, Evans KL, Deary IJ, Wray NR, Visscher PM (2018) GWAS on family history of Alzheimer’s disease. Transl Psychiatry 8, 99. 29777097 PMC5959890 sourceExperimental — accuracy not yet measured
The Results sections report Alzheimer’s-associated loci and genes, but the passages in our copy do not identify SPI1 among them. Searches for “SPI1” and “PU.1” found no passage addressing an association between SPI1 and Alzheimer’s disease. (LLM, conf=0.72)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“elevated brain SPI1 transcript level is associated with AD [8]”
§ Association of SPI1 Haplotypes with Altered SPI1 Gene Expression and Alzheimer’s Disease Risk > INTRODUCTION
What the sources say
- Partly supportedcites [8] Morabito S, Miyoshi E, Michael N, Swarup V (2020) Integrative genomics approach identifies conserved transcriptomic networks in Alzheimer’s disease. Hum Mol Genet 29, 2899– 2919. 32803238 PMC7566321 sourceExperimental — accuracy not yet measured
The Results sections on glial co-expression changes and genetic risk report that an upregulated, AD-associated microglial module contains SPI1. They do not establish that SPI1 transcript levels themselves are elevated in AD brain tissue; a module-level association does not demonstrate the direction of change for every member gene. (LLM, conf=0.82)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“suggesting it regulates SPI1 gene expression through altering the epigenetic landscape [6].”
§ Association of SPI1 Haplotypes with Altered SPI1 Gene Expression and Alzheimer’s Disease Risk > INTRODUCTION
What the sources say
- Could not verifycites [6] Marioni RE, Harris SE, Zhang Q, McRae AF, Hagenaars SP, Hill WD, Davies G, Ritchie CW, Gale CR, Starr JM, Goate AM, Porteous DJ, Yang J, Evans KL, Deary IJ, Wray NR, Visscher PM (2018) GWAS on family history of Alzheimer’s disease. Transl Psychiatry 8, 99. 29777097 PMC5959890 sourceExperimental — accuracy not yet measured
The Results section on summary data-based Mendelian randomisation reports associations involving TOMM40 expression and DNA methylation, not SPI1. Searches for rs78245530 and SPI1-related epigenetic effects found no passage in our copy linking that variant to SPI1 expression or an altered epigenetic landscape. (LLM, conf=0.76)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“rs78245530 is associated with altered DNA methylation states in the frontal cortex”
§ Association of SPI1 Haplotypes with Altered SPI1 Gene Expression and Alzheimer’s Disease Risk > INTRODUCTION
What the sources say
- Could not verifycites [6] Marioni RE, Harris SE, Zhang Q, McRae AF, Hagenaars SP, Hill WD, Davies G, Ritchie CW, Gale CR, Starr JM, Goate AM, Porteous DJ, Yang J, Evans KL, Deary IJ, Wray NR, Visscher PM (2018) GWAS on family history of Alzheimer’s disease. Transl Psychiatry 8, 99. 29777097 PMC5959890 sourceExperimental — accuracy not yet measured
The Methods and Results sections on summary data-based Mendelian randomisation describe methylation-QTL data from prefrontal cortex samples and report methylation associations, but do not link rs78245530 to methylation. A search for rs78245530 in our copy found no passage identifying that variant or supporting the claimed association. (LLM, conf=0.72)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“It is unclear whether SPI1 genetic factors modulate AD risk in populations of non-European descent, as related studies have only been conducted in populations of European descent.”
§ Association of SPI1 Haplotypes with Altered SPI1 Gene Expression and Alzheimer’s Disease Risk > INTRODUCTION
What the sources say
- Partly supportedcites [4] Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, et al. (2019) Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat Genet 51, 414– 430. 30820047 PMC6463297 sourceExperimental — accuracy not yet measured
The Results (Candidate gene prioritization at genome-wide loci; page unavailable) implicate SPI1 in an Alzheimer’s disease risk locus. The Methods (Pre-imputation genotype chip quality control; page unavailable) say that individuals with non-European ancestry were excluded, so this study does not establish whether the association applies to them. The paper does not establish the broader claim that all related studies were conducted only in populations of European descent. (LLM, conf=0.85)
- Partly supportedcites [5] Huang KL, Marcora E, Pimenova AA, Di Narzo AF, Kapoor M, Jin SC, Harari O, Bertelsen S, Fairfax BP, Czajkowski J, Chouraki V, Grenier-Boley B, Bellenguez C, Deming Y, McKenzie A, Raj T, Renton AE, Budde J, Smith A, Fitzpatrick A, Bis JC, DeStefano A, Adams HHH, Ikram MA, Van Der Lee S, Del-Aguila JL, Fernandez MV, Ibañez L, Sims R, Escott-Price V, Mayeux R, Haines JL, Farrer LA, Pericak-Vance MA, Lambert JC, Van Duijn C, Launer L, Seshadri S, Williams J, Amouyel P, Schellenberg GD, Zhang B, Borecki I, Kauwe JSK, Cruchaga C, Hao K, Goate AM (2017) A common haplotype lowers PU.1 expression in my sourceExperimental — accuracy not yet measured
Online Methods > Quality Control (page unavailable) states that individuals with evidence of non-European ancestry were excluded from this paper’s analyses. That supports uncertainty about whether its SPI1 findings apply to non-European populations, but the paper does not establish that all related studies were conducted only in European-descent populations. (LLM, conf=0.86)
- Could not verifycites [6] Marioni RE, Harris SE, Zhang Q, McRae AF, Hagenaars SP, Hill WD, Davies G, Ritchie CW, Gale CR, Starr JM, Goate AM, Porteous DJ, Yang J, Evans KL, Deary IJ, Wray NR, Visscher PM (2018) GWAS on family history of Alzheimer’s disease. Transl Psychiatry 8, 99. 29777097 PMC5959890 sourceExperimental — accuracy not yet measured
The Genotyping methods state that the UK Biobank analysis excluded participants with non-British ancestry. But the paper does not address SPI1 genetic factors or say that related SPI1 studies have only involved populations of European descent. A search of our copy for SPI1 and ancestry terms did not establish the claim. (LLM, conf=0.77)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
56 more claims · 4 with their cited sources checked
Create a free account to see all 99 claims and every source verdict.
- It may state two separate claims as one. 22
- Probably not a substantial claim. 16
- The quote only partly states this claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Furthermore, the SNPs rs3740688 and rs78245530 are significantly associated with Alzheimer's disease in European [23] and Chinese [24] populations, respectively. Interestingly, these variants are also suggested to reduce the risk of developing Alzheimer's disease in these specific populations [23, 24].”
From Targeting Microglial Transcriptional Reprogramming as a Therapy Strategy for Alzheimer's Disease (2026) · cites this paper as [24]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Given that reduced PU.1 expression is protective against AD (Cao et al., 2022; Huang et al., 2017)”
From A novel molecular class that recruits HDAC/MECP2 complexes to PU.1 motifs reduces neuroinflammation (2023) · cites this paper as Cao et al., 2022
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“while polymorphisms in the PU.1 gene SPI1 that reduce PU.1 expression levels lower the risk of AD (Cao et al., 2022) and delay AD onset (Huang et al., 2017).”
From A novel molecular class that recruits HDAC/MECP2 complexes to PU.1 motifs reduces neuroinflammation (2023) · cites this paper as Cao et al., 2022
The cited source says what the claim attributes to it.
In the citing paper
“human SNPs that altered SPI1 expression level were reported to be associated with Alzheimer’s disease (AD) pathogenesis (Cao et al., 2022; Huang et al., 2017).”
From Pu.1/Spi1 dosage controls the turnover and maintenance of microglia in zebrafish and mammals (2025) · cites this paper as Cao et al., 2022
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Yu, G., Wang, L.-G., Han, Y., & He, Q.-Y. (2012) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2011.0118 · Cited by 36,259 · cited 1×
“We subjected significantly downregulated ( Beta < 0, p < 0.05) and upregulated ( Beta > 0, p 0.05) genes associated with SPI1 haplotypes to the enrichGO function from the clusterProfiler package in R [31].”
Influentialfastp: an ultra-fast all-in-one FASTQ preprocessor
Chen, S., Zhou, Y., Chen, Y., & Gu, J. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty560 · Cited by 29,721 · cited 1×
“subjected the raw reads to fastp for quality con145 trol, reads trimming, and filtration [11] and aligned 146”
Self-citationThe Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53221.x · Cited by 25,553
Szklarczyk, D., Gable, A. L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N. T., Morris, J. H., Bork, P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1131 · Cited by 17,749 · cited 1×
“We subsequently queried the STRING database for the protein–protein interaction (PPI) network of genes enriched in different biological processes [32].”
Twelve years of SAMtools and BCFtools
Danecek, P., Bonfield, J. K., Liddle, J., Marshall, J., Ohan, V., Pollard, M. O., Whitwham, A., Keane, T., McCarthy, S. A., Davies, R. M., et al. (2021) · GigaScience · doi:10.1093/gigascience/giab008 · Cited by 15,343 · cited 1×
“Meanwhile, we obtained the haplotypes of Hong Kong Chinese WGS data or European descent cohort data from phased VCF files using the bcftools convert --hapsample function [26].”
Haploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Second-generation PLINK: rising to the challenge of larger and richer datasets
Chang, C. C., Chow, C. C., Tellier, L. C., Vattikuti, S., Purcell, S. M., & Lee, J. J. (2015) · Gigascience · doi:10.1186/s13742-015-0047-8 · Cited by 12,709
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R., Garimella, K. V., Maguire, J. R., Hartl, C., Philippakis, A. A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,456
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674 · cited 1×
“For our survival analysis, we applied a Cox proportional hazards regression to the age of AD onset data from the LOAD cohort using the coxph function from the survival package in R, adjusted for sex and the first three PCs [27].”
The GTEx Consortium atlas of genetic regulatory effects across human tissues
The GTEx Consortium, Aguet, F., Anand, S., Ardlie, K. G., Gabriel, S., Getz, G. A., Graubert, A., Hadley, K., Handsaker, R. E., Huang, K. H., et al. (2020) · Science · doi:10.1126/science.aaz1776 · Cited by 5,547 · cited 2×
“6% of the donors are of European descent) 417 for SPI1 transcript level quantified by RNA-seq in 418 47 human tissues [18] and found that most human 419 tissues express SPI1 transcript (TPM: 2.”
Determining cell type abundance and expression from bulk tissues with digital cytometry
Newman, A. M., Steen, C. B., Liu, C. L., Gentles, A. J., Chaudhuri, A. A., Scherer, F., Khodadoust, M. S., Esfahani, M. S., Luca, B. A., Steiner, D., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0114-2 · Cited by 4,478
Histone H3K27ac separates active from poised enhancers and predicts developmental state
Creyghton, M. P., Cheng, A. W., Welstead, G. G., Kooistra, T., Carey, B. W., Steine, E. J., Hanna, J., Lodato, M. A., Frampton, G. M., Sharp, P. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016071107 · Cited by 4,302
Next-generation genotype imputation service and methods
Das, S., Forer, L., Schönherr, S., Sidore, C., Locke, A. E., Kwong, A., Vrieze, S. I., Chew, E. Y., Levy, S., McGue, M., et al. (2016) · Nature Genetics · doi:10.1038/ng.3656 · Cited by 3,808 · cited 1×
“We imputed and phased genetic data generated 171 from SNP microarrays using the TOPMed imputa172 tion server [21, 22].”
Browning, S. R., & Browning, B. L. (2007) · The American Journal of Human Genetics · doi:10.1086/521987 · Cited by 3,210 · cited 1×
“The phase of the genotypes were determined by Bea-gle 4.0 [14].”
InfluentialAlzheimer Disease Genetics Consortium (ADGC), Kunkle, B. W., The European Alzheimer’s Disease Initiative (EADI), Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE), Genetic and Environmental Risk in AD/Defining Genetic, P. A. E. R. F. A. D. C. (., Grenier-Boley, B., Sims, R., Bis, J. C., Damotte, V., Naj, A. C., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0358-2 · Cited by 2,946
Self-citationExpanded encyclopaedias of DNA elements in the human and mouse genomes
The ENCODE Project Consortium, Abascal, F., Acosta, R., Addleman, N. J., Adrian, J., Afzal, V., Ai, R., Aken, B., Akiyama, J. A., Jammal, O. A., et al. (2020) · Nature · doi:10.1038/s41586-020-2493-4 · Cited by 2,378
Self-citationSequencing of 53,831 diverse genomes from the NHLBI TOPMed Program
Taliun, D., Harris, D. N., Kessler, M. D., Carlson, J., Szpiech, Z. A., Torres, R., Taliun, S. A. G., Corvelo, A., Gogarten, S. M., Kang, H. M., et al. (2021) · Nature · doi:10.1038/s41586-021-03205-y · Cited by 2,213 · cited 1×
“We imputed and phased genetic data generated 171 from SNP microarrays using the TOPMed imputa172 tion server [21, 22].”
Self-citationRole of Genes and Environments for Explaining Alzheimer Disease
Gatz, M., Reynolds, C. A., Fratiglioni, L., Johansson, B., Mortimer, J. A., Berg, S., Fiske, A., & Pedersen, N. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.168 · Cited by 1,798 · cited 1×
“AD has a 35 strong hereditary component, estimated at 74–79% 36 [1, 2], suggesting its progression is highly influ37”
Matrix eQTL: ultra fast eQTL analysis via large matrix operations
Shabalin, A. A. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts163 · Cited by 1,694 · cited 1×
“haplotypes with transcriptome in the GTEx dataset, 238 we used the linear model from the MatrixEQTL pack239 age in R [28], adjusted for age, sex, the first three PCs, 240 and RNA integrity number.”
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
Yamazaki, Y., Zhao, N., Caulfield, T. R., Liu, C.-C., & Bu, G. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0228-7 · Cited by 1,425 · cited 1×
“The coding mutation APOE (cid:4) 4 is the most well-accepted AD risk genetic factor: having the APOE (cid:4) 4 coding mutation(s) increases AD risk 3–15 fold [3].”
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130 · cited 2×
“tor that regulates the expression of immune-related 46 genes in myeloid cells [7], is associated with AD 47 [4–6].”
Morris, J. C., Weintraub, S., Chui, H. C., Cummings, J., DeCarli, C., Ferris, S., Foster, N. L., Galasko, D., Graff-Radford, N., Peskind, E. R., et al. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213865.09806.92 · Cited by 950
Han, B., & Eskin, E. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.04.014 · Cited by 680
Genetic variability in the regulation of gene expression in ten regions of the human brain
UK Brain Expression Consortium, Ramasamy, A., North American Brain Expression Consortium, Trabzuni, D., Guelfi, S., Varghese, V., Smith, C., Walker, R., De, T., Coin, L., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3801 · Cited by 644 · cited 1×
“p2) [18], the BRAINEAC database 166 [19], and the Cardiogenics Study (EGAC0000100 167 0088) [20].”
The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans
Weiner, M. W., Aisen, P. S., Jack, C. R., Jagust, W. J., Trojanowski, J. Q., Shaw, L., Saykin, A. J., Morris, J. C., Cairns, N., Beckett, L. A., et al. (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.03.007 · Cited by 599
Self-citationGWAS on family history of Alzheimer’s disease
Marioni, R. E., Harris, S. E., Zhang, Q., McRae, A. F., Hagenaars, S. P., Hill, W. D., Davies, G., Ritchie, C. W., Gale, C. R., Starr, J. M., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0150-6 · Cited by 564 · cited 4×
“Specifically, three single-nucleotide polymorphisms (SNPs) of SPI1 —rs3740688, rs1057233, and rs78245530—protect against AD risk in populations of European descent [4–6].”
InfluentialSchwartzentruber, J., Cooper, S., Liu, J. Z., Barrio-Hernandez, I., Bello, E., Kumasaka, N., Young, A. M. H., Franklin, R. J. M., Johnson, T., Estrada, K., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00776-w · Cited by 532
Lau, S.-F., Cao, H., Fu, A. K. Y., & Ip, N. Y. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008762117 · Cited by 476 · cited 1×
“:3) affects SPI1 gene expression in specific brain cell types, we analyzed a previously reported single-nucleus RNA sequencing(snRNA-seq)datasetofthehumanfrontal cortex[41].”
Self-citationA common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease
The International Genomics of Alzheimer's Project, Huang, K.-L., Initiative, T. A. D. N., Marcora, E., Pimenova, A. A., Di Narzo, A. F., Kapoor, M., Jin, S. C., Harari, O., Bertelsen, S., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4587 · Cited by 423
An Object-Oriented Framework for Robust Multivariate Analysis
Todorov, V., & Filzmoser, P. (2009) · Journal of Statistical Software · doi:10.18637/jss.v032.i03 · Cited by 420 · cited 1×
“243 For our association analyses of microarray data from 244 the Cardiogenics study and BRAINEAC database, 245 we subjected the normalized signal intensity data to 246 robust linear regression using the lmrob function from 247 the robustbase package in R [29].”
Regulatory genomic circuitry of human disease loci by integrative epigenomics
Boix, C. A., James, B. T., Park, Y. P., Meuleman, W., & Kellis, M. (2021) · Nature · doi:10.1038/s41586-020-03145-z · Cited by 416
Heritability for Alzheimer’s disease: the study of dementia in Swedish twins
Gatz, M., Pedersen, N. L., Berg, S., Johansson, B., Johansson, K., Mortimer, J. A., Posner, S. F., Viitanen, M., Winblad, B., & Ahlbom, A. (1997) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/52a.2.m117 · Cited by 413 · cited 1×
“AD has a 35 strong hereditary component, estimated at 74–79% 36 [1, 2], suggesting its progression is highly influ37”
Alzheimer's Neurofibrillary Changes: A Topographic Study
HIRANO, A. (1962) · Archives of Neurology · doi:10.1001/archneur.1962.04210030065009 · Cited by 402
On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles
Morris, R. W., & Kaplan, N. L. (2002) · Genetic Epidemiology · doi:10.1002/gepi.10200 · Cited by 369 · cited 1×
“Compared to SNP-based studies, haplotype analysis can increase the statistical power of genetic analysis and identify key disease-associated SNPs or haplotypes [46].”
Corces, M. R., Shcherbina, A., Kundu, S., Gloudemans, M. J., Frésard, L., Granja, J. M., Louie, B. H., Eulalio, T., Shams, S., Bagdatli, S. T., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-00721-x · Cited by 358 · cited 1×
“We queried DNase sequenc274 ing (DNase-seq) and chromatin immunoprecipitation 275 sequencing (ChIP-seq) data of the epigenetic mark276 ers H3K4me3 and H3K27ac, derived from the 277 mononuclear cell and frontal cortex data in the 278 EpiMap database [35], as well as single-cell assay 279 for transposase-accessible chro…”
McCaw, Z. R., Lane, J. M., Saxena, R., Redline, S., & Lin, X. (2020) · Biometrics · doi:10.1111/biom.13214 · Cited by 249 · cited 2×
“To examine the association of the SPI1 haplotypes with cognition, we applied the rank-based inverse normal transformation to the Mini–Mental State Examination (MMSE) scores from the ADNI cohort using the rankNorm function from the RNOmni package in R [24].”
Cdk5: a multifaceted kinase in neurodegenerative diseases
Cheung, Z. H., & Ip, N. Y. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.11.003 · Cited by 233 · cited 1×
“CDK5 is essential for synaptic plasticity and neurode650 generation [51].”
Self-citationExploring Diallelic Genetic Markers: The HardyWeinberg Package
Graffelman, J. (2015) · Journal of Statistical Software · doi:10.18637/jss.v064.i03 · Cited by 223 · cited 1×
“We evaluated the Hardy–Weinberg equilibrium of 186 the SPI1 SNPs using the HWExact function from the 187 HardyWeinberg package in R [25].”
Liu, C.-J., Fu, X., Xia, M., Zhang, Q., Gu, Z., & Guo, A.-Y. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa783 · Cited by 134 · cited 1×
“Accordingly, we queried the miR-NASNP database and found that rs1057233 may alter the binding affinity of the 3’-UTR of SPI1 with multiple miRNAs (Supplementary Table 13) [44].”
EADI consortium, G. C., Lambert, J.-C., Grenier-Boley, B., Harold, D., Zelenika, D., Chouraki, V, Kamatani, Y., Sleegers, K., Ikram, M. A., Hiltunen, M., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.14 · Cited by 129
Lee, J. H. (2008) · Archives of Neurology · doi:10.1001/archneur.65.11.1518 · Cited by 127 · cited 1×
“…from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset (http://adni.loni.usc.edu) [15], the National Institute on Aging (NIA) Alzheimer’s Disease Centers (ADC) Cohort (phs000372.v2.p1) [16], and the NIA Late Onset Alzheimer’s Disease (LOAD) Family Study (phs000168.v2.p2) [17].”
Non-coding variability at the APOE locus contributes to the Alzheimer’s risk
Zhou, X., Chen, Y., Mok, K. Y., Kwok, T. C. Y., Mok, V. C. T., Guo, Q., Ip, F. C., Chen, Y., Mullapudi, N., Initiative, A. D. N., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10945-z · Cited by 120 · cited 1×
“ysis in the APOE locus identified risk haplotypes 598 that are independent of the APOE 4 allele [48].”
Self-citationAlzheimer's-associated PU.1 expression levels regulate microglial inflammatory response
Pimenova, A. A., Herbinet, M., Gupta, I., Machlovi, S. I., Bowles, K. R., Marcora, E., & Goate, A. M. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105217 · Cited by 120 · cited 1×
“…epigenetic profiles of specific SPI1 genetic variant-harboring regions provide insights into the functions of those regions, functional studies may help elucidate the mechanisms by which the SPI1 haplotypes modulate SPI1 gene expression and hence alter AD-associated functions of microglia [52, 53].”
Lau, S.-F., Chen, C., Fu, W.-Y., Qu, J. Y., Cheung, T. H., Fu, A. K. Y., & Ip, N. Y. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107530 · Cited by 114
Self-citationIntegrative genomics approach identifies conserved transcriptomic networks in Alzheimer’s disease
Morabito, S., Miyoshi, E., Michael, N., & Swarup, V. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa182 · Cited by 74 · cited 2×
“Interestingly, while elevated brain SPI1 transcript level is associated with AD [8], rs1057233 tags a common haplotype that lowers SPI1 transcript level in myeloid cells [5].”
Hikami, K., Kawasaki, A., Ito, I., Koga, M., Ito, S., Hayashi, T., Matsumoto, I., Tsutsumi, A., Kusaoi, M., Takasaki, Y., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30188 · Cited by 58
Genome-Wide Haplotype Analysis of Cis Expression Quantitative Trait Loci in Monocytes
Garnier, S., Truong, V., Brocheton, J., Zeller, T., Rovital, M., Wild, P. S., Ziegler, A., The Cardiogenics Consortium, Munzel, T., Tiret, L., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003240 · Cited by 56 · cited 2×
“p2) [18], the BRAINEAC database 166 [19], and the Cardiogenics Study (EGAC0000100 167 0088) [20].”
Genetic and polygenic risk score analysis for Alzheimer's disease in the Chinese population
Zhou, X., Chen, Y., Ip, F. C. F., Lai, N. C. H., Li, Y. Y. T., Jiang, Y., Zhong, H., Chen, Y., Zhang, Y., Ma, S., et al. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12074 · Cited by 38 · cited 1×
“AD cohort [39] (n = 333 patients with AD, n = 721 298 NCs; Supplementary Table 1).”
Self-citationKunkle, B., Grenier-Boley, B., Sims, R., Bis, J., Naj, A., Boland, A., Vronskaya, M., van der Lee, S., Amlie-Wolf, A., Bellenguez, C., et al. (2018) · doi:10.1101/294629 · Cited by 35
Self-citationForestPMPlot: A Flexible Tool for Visualizing Heterogeneity Between Studies in Meta-analysis
Kang, E. Y., Park, Y., Li, X., Segrè, A. V., Han, B., & Eskin, E. (2016) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.116.029439 · Cited by 33 · cited 1×
“A forest plot for our meta-analysis was generated by ForestPMPlot [38].”
Cited by
Alzheimer’s Disease: An Updated Overview of Its Genetics
Andrade-Guerrero, J., Santiago-Balmaseda, A., Jeronimo-Aguilar, P., Vargas-Rodríguez, I., Cadena-Suárez, A. R., Sánchez-Garibay, C., Pozo-Molina, G., Méndez-Catalá, C. F., Cardenas-Aguayo, M.-D.-C., Diaz-Cintra, S., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043754 · Cited by 336
“1 (SPI1), involved in the expression of immune-related genes in myeloid cells, could contribute to AD by regulating key pathways associated with the immune response and altering the epigenetic landscape [47,48].”
Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
Miao, J., Ma, H., Yang, Y., Liao, Y., Lin, C., Zheng, J., Yu, M., & Lan, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1201982 · Cited by 293
“SPI1 (Cao et al., 2022) rs1057233 Transcription factor PU.”
Insights into Alzheimer’s disease from single-cell genomic approaches
Murdock, M. H., & Tsai, L.-H. (2023) · Nature Neuroscience · doi:10.1038/s41593-022-01222-2 · Cited by 148
Microglial efferocytosis: Diving into the Alzheimer’s disease gene pool
Romero-Molina, C., Garretti, F., Andrews, S. J., Marcora, E., & Goate, A. M. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.015 · Cited by 111
Ralvenius, W. T., Andresen, J. L., Huston, M. M., Penney, J., Bonner, J. M., Fenton, O. S., Langer, R., & Tsai, L. (2024) · Advanced Materials · doi:10.1002/adma.202309225 · Cited by 78
Metadata
- Authors
- Cao, H., Initiative, A. D. N., Zhou, X., Chen, Y., Ip, F. C. F., Chen, Y., Lai, N. C. H., Lo, R. M. N., Tong, E. P. S., Mok, V. C. T., Kwok, T. C. Y., Fu, A. K. Y., & Ip, N. Y.
- Affiliations
- Hong Kong University of Science and Technology (HK)
- Chinese Academy of Sciences (CN)
- Chinese University of Hong Kong (HK)
- Corresponding author
- Ip, Nancy Y.
- ORCID
- Venue
- Journal of Alzheimer s Disease
- Publisher
- SAGE Publications
- Published
- 2022-04-19
- Volume
- 86
- Issue
- 4
- Pages
- 1861-1873
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC9108557
- OpenAlex
- W4214632026
- Semantic Scholar
- 157c7995870ade5d6e1ffeb8169887063a4e79b9
- Cited by
- 29
- References
- 53
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 7 · 2023: 6 · 2022: 1
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
- Funders
- Alzheimer's Disease Neuroimaging Initiative
- National Natural Science Foundation of China (32061160472, 2018B030336001, 2019003, 2018YFE0203600, 2019B1515130004, 2019001)
- University Grants Committee (T13-607/12R, AoE/M-604/16)
- Innovation and Technology Commission (ITC PD/17-9)
- Shenzhen Knowledge Innovation Program (JCYJ20180507183642005)
- National Institute on Aging
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- PU.1, Alzheimer's disease
- MeSH terms
- Proto-Oncogene Protein Spi-1, Alzheimer Disease, China, Haplotypes, Humans, Proto-Oncogene Proteins, Trans-Activators, Gene Expression, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-17, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-17 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.